Yves J. L. Bodar

Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -

B.H.E. Jansen, Yves J. L. Bodar, Gerben J.C. Zwezerijnen et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 104 citations · Full text

Detection of prostate cancer with 18F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial

Yves J. L. Bodar, B.H.E. Jansen, J. Patrick van der Voorn et al. · World Journal of Urology · 2020 · 45 citations · Full text

Repeatability of Quantitative ¹⁸F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer

B.H.E. Jansen, Matthijs C. F. Cysouw, André N. Vis et al. · Journal of Nuclear Medicine · 2020 · 28 citations · Full text

Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study

Yves J. L. Bodar, Gerben J.C. Zwezerijnen, Patrick J. van der Voorn et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 27 citations · Full text

Standardised uptake values as determined on prostate‐specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer

Yves J. L. Bodar, Hans Veerman, Dennie Meijer et al. · British Journal of Urology · 2022 · 26 citations · Full text